Those with obesity already have high levels of leptin in their body. It’s been found that people with sleep apnea can also have up to 50% more of this hormone compared to those who don’t have ...
In my twenties, I saw my episodes as a (mostly) harmless quirk, akin to sleep walking. They didn’t always keep me in my family’s good graces, but I felt otherwise fine. I brushed them off for years.
Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...
11d
KYW Radio Philadelphia on MSNMedical Report: FDA approves weight loss drug to treat sleep apneaAs many as 17% of men and 34% of women in the United States suffer from sleep apnea, and the numbers are increasing. KYW ...
Background: A 60-year-old male with obesity (body-mass index 43 kg/m 2) presented with recurrent symptomatic atrial fibrillation (AF), which he had had since age 41 years. The AF was refractory to ...
For people with both moderate-to-severe sleep apnea and obesity, the FDA-approved prescription medication Zepbound (tirzepatide) may help reduce body weight and, in turn, improve breathing.
According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US adults. While there are many clinical treatments available to effectively ...
Wesper, a leader in advanced home sleep apnea testing (HSAT), is transforming how obesity and sleep apnea are managed by ...
Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...
Diagnosis AF, atrial flutter, tachycardia–bradycardia syndrome, obstructive sleep apnea and morbid obesity. Management Antiarrhythmic drug therapy, DC cardioversion, anticoagulation, atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results